PEDIATRIC INFECTIOUS DISEASE JOURNAL, cilt.38, sa.8, ss.866-872, 2019 (SCI-Expanded)
Background: In an exploratory analysis of an inactivated quadrivalent influenza vaccine (IIV4) trial in children 6-35 months without risk factors for influenza, we evaluated clinical presentation of influenza illness and vaccine impact on health outcomes.